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There is a growing body of evidence that links nutrition to muscle mass, strength and function in older
adults, suggesting that it has an important role to play both in the prevention and management of
sarcopenia. This review summarises the discussions of a working group [ESCEO working group meeting
8th September 2016] that met to review current evidence and to consider its implications for preventive
and treatment strategies. The review points to the importance of ‘healthier’ dietary patterns that are
adequate in quality in older age, to ensure sufficient intakes of protein, vitamin D, antioxidant nutrients
and long-chain polyunsaturated fatty acids. In particular, there is substantial evidence to support the
roles of dietary protein and physical activity as key anabolic stimuli for muscle protein synthesis.
However, much of the evidence is observational and from high-income countries. Further high-quality
trials, particularly from more diverse populations, are needed to enable an understanding of dose and
duration effects of individual nutrients on function, to elucidate mechanistic links, and to define optimal
profiles and patterns of nutrient intake for older adults.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).gy Unit, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK. Fax: þ44 0 23 8070
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Estimated linear changes in energy intake (kcal/day) in 922men and 879women
over a 12-year follow-up period, according to (4-year) age group at baseline [9].
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Healthy ageing is defined by the World Health Organisation as
‘the process of developing and maintaining the functional ability that
enables wellbeing in older age’ [1], with functional ability made up of
an individual's intrinsic capacity (a composite of all physical and
mental capacities), their relevant environmental characteristics and
the interactions between these. The WHO report on Ageing and
Health, published in 2015, recognises the growing evidence of the
importance of health-related behaviours, such as engaging in
physical activity and maintaining adequate nutrition, as influences
on intrinsic capacity in older age, and separate from effects on risk
of non-communicable diseases. Their broader impact on intrinsic
capacity is less extensively researched, but may be central to stra-
tegies to reverse or delay declines in functional ability, including
conditions such as frailty [1].
Sarcopenia, the loss of muscle mass and physical function that
occurs with advancing age, is a common condition that is associ-
ated with huge personal and financial costs [2,3]. Present in an
estimated 50%e70% of frail individuals, it is widely recognised, now
with an ICD code (ICD-10-CM) [4]. Loss of muscle mass, that results
from the shrinking (atrophy) and elimination of muscle fibres, may
be an expected component of the ageing process [5]. However,
variation in the rates of decline in muscle mass and strength across
the population [6] point to the influence of modifiable behavioural
factors such as diet and lifestyle in the aetiology of sarcopenia,
suggesting that these factors may be effective both for its preven-
tion and treatment. This review documents the discussions of a
working group [ESCEO working group meeting 8th September
2016] that reviewed current evidence that links diet to muscle
mass, strength and physical function in older age, and considered
the implications of this evidence for preventive and treatment
strategies.
2. Ageing and nutrition
There is a significant decline in food and energy intake with
increasing age, as energy needs decrease [7], amounting to an
average fall of around 25% between the ages of 40 and 70 years [8].
Older adults may eat more slowly, consume smaller meals, and eat
fewer snacks between meals than younger adults [8]. In a recent
analysis of longitudinal intake data, Otsuka and colleagues showed
that energy intakes fell in both men and women from their
40se70s (Fig. 1), but notably, among men, the reduction was
greater in the older age groups [9].
Declining food and energy intakes occur alongside changes in
appetite and a lack of hunger, and have been described as the
‘anorexia of ageing’ [10]. The mechanisms are not fully understood
but include a range of physiological, psychological and social factors
that influence appetite and food consumption. Specific age-related
changes include loss of acuity in taste, smell and sight, changes in
the secretion and peripheral action of appetite hormones, effects on
gastrointestinal motility, chewing and swallowing difficulties, as
well as other effects of chronic disease that can affect food intake
[8,10,11]. The negative consequences of these changes may be
compounded by the effects of functional impairments that impact
on ability to access and prepare food, psychological problems such
as depression and dementia, as well as the social effects of living
and eating alone [12].
Low food intakes and monotonous diets put older people at risk
[13] because, as total food intake falls, for most nutrients there is a
corresponding decline in intake [7]. Exact estimates of the preva-
lence of poor nutrition in older populations differ according to
definitions used and the groups studied. However, a consistentPlease cite this article in press as: Robinson SM, et al., Does nutrition pla
Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.08.016message from studies of community-dwelling adults is that poor
nutrition is common in older age, with substantial numbers of older
adults who are malnourished or at risk of malnutrition. For
example, in a pooled analysis of data from 12 countries, approxi-
mately two-thirds of older study participants were identified as
being at nutritional risk or malnourished [14]. The estimated eco-
nomic costs of disease-related malnutrition are high [15,16]. Sar-
copenia frequently co-exists with malnutrition in older patients
[17], and poor nutritional status is associated with the onset of
frailty [18]. Routine screening of nutritional status and early diag-
nosis of malnutrition in older adults is therefore essential, both in
the community as well as in hospital settings. However, this may
not be prioritised; for example, in the Survey of Health, Ageing and
Retirement in Europe, a third of adults over the age of 80 years
reported that they had not been weighed by their general practi-
tioner [19]; and older adults commonly report that they do not
receive advice on diet from their physician or other health pro-
fessionals. The situation is worse in low and middle-income
countries.
Declining food intakes in older age contribute to weight loss,
with implications for muscle mass, strength and physical functiony a role in the prevention and management of sarcopenia?, Clinical
Fig. 2. Fractional mixed muscle protein synthesis rates (FSR) in healthy young and
older men in the post-absorptive state (n ¼ 34 young, n ¼ 72 older) and post-prandial
(n ¼ 35 young, n ¼ 40 older) state, following ingestion of 20 g protein. Significantly
different comparing post-absorptive and post-prandial values for each group: **
(P < 0.01), *** (P < 0.001); significantly different comparison of older and young men:
yy (P < 0.01) [24].
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recognised for a long time. However, much of the research
exploring the effects of diet onmuscle mass and physical function is
relatively recent [21]. A number of interventions has been studied,
ranging from provision of nutritional support, to supplementation
with specific nutrients. The nutrients that have been most consis-
tently linked to the components of sarcopenia and frailty in
observational studies include protein, vitamin D, antioxidant nu-
trients (that include carotenoids, selenium and vitamins E and C)
and long-chain polyunsaturated fatty acids. This review considers
current evidence of their effects on muscle mass and strength and
physical function in older people. Comment is also included on the
roles of other dietary components (dairy and nitrate-rich foods)
and the importance of overall dietary patterns.
3. Nutrition, muscle mass, strength and physical function
3.1. Protein
Dietary protein provides amino acids that are needed for the
synthesis of muscle protein, as well as acting as an anabolic stim-
ulus, with direct effects on protein synthesis. For example, in a
feeding study that provided 20 g of labelled casein to examine the
effects of dietary protein ingestion on muscle protein synthesis in
younger adults, Groen and colleagues demonstrated thatmore than
half (~55%) of the protein-derived amino acids became available in
the circulation over a 5-hour period following the meal, with ~11%
of these amino acids (2.2 ± 0.3 g) incorporated in de novo muscle
protein over that period [22]. A key concern for older adults is that
the anabolic response to protein ingestion may be blunted, sug-
gesting that protein requirements need to be higher in order to
maintain nitrogen balance and prevent loss of muscle mass and
strength [23]. There has been some inconsistency across studies in
the extent to which the anabolic response to protein is reduced in
older age [24], and there is debate regarding the importance of low
protein intakes, and whether they are causally related to losses of
muscle mass and strength in older adults [25]. Whilst some of the
inconsistency in study findings may be due to differences in
methodological approaches and based on small studies with
limited statistical power, a clear understanding of changes in syn-
thetic responses to protein feeding in older age is essential to
ensure the protein needs of older adults are met. An important
contribution to this evidence is a recent publication by Wall and
colleagues, inwhich they bring together data from a series of stable
isotope tracer studies to enable comparison of post-absorptive and
postprandial protein synthesis rates in larger groups of young and
older men (Fig. 2) [24]. Muscle protein synthesis in the post-
absorptive state did not differ between groups. However, synthe-
sis rates after ingestion of 20 g protein were 16% lower in the older
men, with a substantial difference between young and older men in
the change in rates from the post-absorptive to the postprandial
state [24].
There is some observational evidence that links low protein
intakes to losses of muscle mass and strength in older age. For
example, in the Health, Aging and Body Composition Study, a
greater loss of lean mass, assessed using dual-energy X-ray ab-
sorptiometry, was found over a 3-year follow-up period among
older community-dwelling men and women who had low energy-
adjusted protein intakes at baseline. The differences were sub-
stantial, such that the participants with protein intakes in the top
fifth of the distribution (mean intake ± SD; 1.2 ± 0.4 g/kg body
weight) lost 40% less lean mass and appendicular lean mass over
the follow-up periodwhen comparedwith those in the bottom fifth
(0.8 ± 0.3 g/kg) [26]. Consistent with this finding, in more recent
follow-up studies of the Women's Health Initiative [27] and thePlease cite this article in press as: Robinson SM, et al., Does nutrition pla
Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.08.016Framingham Offspring cohort [28], higher intakes of protein at
baselinewere associatedwith reduced loss of grip strength over the
period of study. But, in a prospective cohort study of community-
dwelling older adults in Tasmania, whilst energy-adjusted protein
intake was a positive predictor of change in appendicular lean
mass, differences in grip strength were not observed [29]. Overall,
the evidence suggests that protein supplementation should have
the potential to slow sarcopenic muscle loss, particularly among
older adults with low habitual intakes. However, whilst there are
studies that show positive effects, evidence of functional benefits of
supplementation is mixed [30].
Branched-chain amino acids have been shown to increase
skeletal muscle protein synthesis and net balance, and supple-
mentation with leucine, isoleucine, and valine has been used to
improve athletic performance and to attenuate muscle loss [31].
Although there are some differences between individual studies
[32], a systematic review and meta-analysis concluded that leucine
ingestion increases muscle protein fractional synthetic rate in older
individuals, andmay be of benefit to address age-related declines in
muscle mass [33]. Consistent with this finding, greater leucine
intake was found to be associated with long-term lean body mass
retention in a healthy older Danish population [34]. There is also
interest in b-hydroxy-b-methylbutyrate (HMB), a key metabolite of
leucine, with demonstrated effects on protein synthesis and protein
breakdown [35,36]. Findings from a recent study suggested an age-
related decline in endogenous HMB; plasma concentrations were
positively correlated with appendicular lean mass and muscle
strength in young and older adults [37]. HMB supplementation has
been tested in older adults, and there is a growing body of evidence
that suggests HMB may help slow muscle loss and improve mea-
sures of muscle strength [5]. For example, in healthy older adults,
HMB supplementation preserved muscle mass during a 10-day
period of bed rest [38]. A meta-analysis of seven randomized
controlled trials of HMB supplementation in older adults showed
greater muscle mass gain in the intervention groups, compared
with the control groups [39]. The authors concluded that HMB
supplementation may be useful in the prevention of muscle atro-
phy but further studies are needed to determine the precise effects
of HMB on muscle strength and physical function in older adults
[39].
There is greater interest in the combined effects of protein
supplementation and exercise to increase postprandial protein
synthesis to promote muscle protein accretion. Resistance exercise
increases muscle protein synthesis [40], and synergistic effects of
resistance exercise and protein ingestion have been described in
some studies [41], suggesting that exercise may enable greater usey a role in the prevention and management of sarcopenia?, Clinical
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therefore is that dietary protein digestion and absorption kinetics
after exercise appear to be comparable when measured following a
single meal in young and older men [42](Fig. 3).
Until recently, the implications of these experimental findings
for longer-term strategies to prevent loss of muscle mass and
strength were unclear. However, pooled estimates from a meta-
analysis of 22 RCTs of protein supplementation during prolonged
(more than 6 weeks) resistance-type exercise training, have
confirmed significantly greater gains in fat free mass, type I and II
muscle fibre cross sectional area and 1-RM leg press strength in
supplemented participants, when compared with participants
receiving exercise training alone [43]. The augmented response to
exercise training resulting from protein supplementation was seen
both in older (50 years or older) and younger (49 years or less)
participants. In order to reduce heterogeneity between studies,
only healthy subject groups were included in this meta-analysis,
and the authors suggest that there is potential for greater bene-
fits among frail older adults whose habitual protein intakes are low
[43]. Although trials of resistance exercise training combined with
protein/amino acid supplementation of older adults (65 years and
older) have not always found interactive effects on muscle mass,
strength and physical performance [44], consistent with this sug-
gestion, a trial of frail older men andwomen showed that lean body
mass increased in the protein-supplemented group (in addition to
resistance-type exercise training), whereas there was no change in
the placebo (exercise only) group [45]. Although comparable effects
have also been described in an intervention study that provided
additional lean red meat, to increase dietary protein intake among
older adults, combined with resistance exercise training [46], a
recent trial of supplementation of mobility-limited older adults
with whey protein concentrate (40 g/day), in combination with
progressive high-intensity resistance training, did not result in
statistically significant differences in lean mass, muscle cross
sectional area or stair-climbing performance, when compared to
the control group [47]. An additional consideration is that the
muscle protein synthetic response to protein ingestion in older age
is affected by the amount and pattern of protein intake [48] as well
as other dietary components, such as carbohydrate, consumed at
the same time [49]. There is also evidence that effects on muscle
protein synthetic response differ according to the protein source,
with lesser anabolic effects of plant proteins observed in compar-
ison with animal protein [50]. This may be due to differences in
content and balance of amino acids, particularly to the relatively
lower leucine content of plant proteins. Although strategies haveFig. 3. Mean mixed-muscle protein fractional synthetic rates (FSR) after protein
ingestion in young (n ¼ 24) and older (n ¼ 24) men at rest and after exercise based on
L-[1-13C]phenylalanine (ingested tracer) enrichment. Data were analysed by ANOVA
(age $ exercise): age effect, P ¼ 0.62; exercise effect, P ¼ 0.05; age  exercise effect,
P ¼ 0.52 [42].
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Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.08.016been proposed to improve the anabolic properties of plant proteins,
evidence of their effectiveness is currently lacking [50]. An addi-
tional consideration is the distribution of protein intake across
different meals [51,52]; this was highlighted in a recent analysis of
NHANES data, showing that more frequent consumption of meals
containing at least 30 g of protein was associated with greater leg
lean mass and knee extensor muscle strength [53]. Further data are
needed to define and test recommendations for optimal dietary
profiles, amounts of patterns of protein intake and their interaction
with exercise in older adults.
There are many clear benefits of exercise training for older
adults that include effects on muscle mass and strength. Whilst
heterogeneity in the adaptive response (lean body mass, muscle
fibre size, strength, and physical function) to prolonged resistance-
type exercise training was described in a recent retrospective
analysis of data from older men and women, an important finding
is that there were no non-responders [54]. Population approaches
to increase resistance-type exercise among older people therefore
have enormous potential to promote better physical function and to
support healthier ageing. Declining levels of physical activity [55]
and increased sedentary behaviour [56], both commonly
observed, are therefore challenges to the health of older adults. The
combination of physical inactivity and high levels of sedentary
behaviour can result in a diminished muscle protein synthetic
response to protein ingestion, making a significant contribution to
loss of muscle mass and strength in older adults [56], further
exacerbated when inactivity is enforced following injury or illness.
Successive short periods of bed-rest may be particularly important
in the development of sarcopenia as their effects accumulate across
the lifecourse. This is represented in themodel proposed by English
& Paddon-Jones (Fig. 4), in which age-related muscle loss is punc-
tuated by episodes of acute illness or injury; each ‘catabolic crisis’ is
characterized by accelerated muscle loss and followed by incom-
plete recovery [57].
Although the mechanisms that underpin the effects of muscle
disuse are not fully understood, a recent study of younger adults
has shown that one-legged knee immobilization over 5 days was
sufficient to lower post-absorptive myofibrillar protein synthesis
rates and to induce anabolic resistance to protein ingestion [58].
Further research is needed to define nutritional and/or exercise
interventions that will improve muscle sensitivity and prevent or
attenuate muscle loss during periods of disuse [59], and to deter-
mine the preventive effects, for healthy older community-dwelling
adults, of breaking up prolonged bouts of sedentary activity on
skeletal muscle mass and physical function [56].Fig. 4. Proposed model of age-related muscle loss punctuated by episodes of acute
illness or injury [57].
y a role in the prevention and management of sarcopenia?, Clinical
Table 1
Meta-analyses, published between 2004 and 2014, of supplemental vitamin D trials
to prevent falls (OR odds ratio; RR relative risk; RaR rate ratio).
Effect of supplementation on falls
2004 Bischoff-Ferrari HA et al. [88] 22% [OR 0.78 (95% CI 0.64, 0.92)]
2007 Jackson C et al. [89] 12% [RR 0.88 (95% CI 0.78, 1.00)]
2008 O'Donnell S et al. [90] 34% [OR 0.66 (95% CI 0.44, 0.98)]
2008 Richy F et al. [91] 21% [RR 0.79 (95% CI 0.64, 0.96)]
2009 Bischoff-Ferrari HA et al. [92] 19% [RR 0.81 (95% CI 0.71, 0.92)]
2010 Kalyani RR et al. [93] 14% [RR 0.86 (95% CI 0.79, 0.93)]
2010 Michael YL et al. [94] 17% [RR 0.83 (95% CI 0.75, 0.91)]
2011 Murad MH et al. [95] 14% [OR 0.86 (95% CI 0.77, 0.96)]
2012 Cameron ID et al. [96] 37% [RaR 0.63 (95% CI 0.46, 0.86)]
2014 Bolland M et al. [97] 5% [RR 0.95 (95% CI 0.89, 1.02)]
S.M. Robinson et al. / Clinical Nutrition xxx (2017) 1e12 5In summary, there is significant evidence of the importance of
protein intake and physical activity as principal anabolic stimuli for
muscle protein synthesis. Physical activity sensitizes skeletal
muscle tissue to the anabolic properties of amino acids. While the
additional benefits of appropriate nutritional support may vary,
depending on the exercise programme and the age and status of the
participants, combining exercise with appropriate nutritional
support is likely to be an important strategy to maintain muscle
mass and strength in older age. A number of expert groups have
proposed an increase in dietary protein recommendations for older
age groups to 1.0e1.2 g/kg body weight per day [60,61]. However,
these reviews also highlight the need for further trial data, partic-
ularly with respect to protein source and pattern of consumption, to
understand the potential for beneficial effects of additional dietary
protein on physical function [60,62].
3.2. Vitamin D
Loss of muscle mass and vitamin D deficiency often occur
together and are interrelated; both are linked to common clinical
outcomes that include weakness, falls and frailty in older age
[63,64]. The mechanisms by which vitamin D affects muscle
strength and function are not fully understood, but may be medi-
ated by the vitamin D receptor (VDR). VDR and 1-alpha hydroxylase
are expressed in muscle tissue, and notably, VDR knockout mice
have small and variable muscle fibres [63,65,66]. The number of
VDR present in human muscle tissue has been shown to decline
with age [67,68]. However, an important recent finding is that VDR
expression can be changed by vitamin D supplementation [69]. For
example, in a 4-month RCT inwhich older mobility-limited women
were given 4000 IU vitamin D3 or placebo, a greater change in
intramyonuclear VDR concentration was found among supple-
mented women, with more pronounced differences observed in
Type II muscle fibres [70]. Furthermore, there was a strong corre-
lation between the change in serum 25(OH)D over the trial period
and percent change in VDR concentration (r ¼ 0.87, P < 0.001),
providing supportive evidence of sustained clinical effects of
vitamin D supplementation on muscle function [70]. In addition,
findings from recent studies suggest a potential anti-inflammatory
role for vitamin D. For example, among older adults in the
InCHIANTI Study, there was an inverse association between serum
25(OH)D concentration and the proinflammatory cytokine IL-6
[71]. Further evidence has come from a study of older, mobility-
limited adults, in which intramuscular VDR protein concentration
was found to be positively associated with intramuscular IL-6 gene
expression, but negatively associated with intramuscular IL-6
protein concentration, suggesting a relationship between VDR
and IL-6 in human skeletal muscle [72].
There is substantial clinical and epidemiological evidence that
links vitamin D status in older age to differences in muscle strength
and function. For example, more than a decade ago, Visser and
colleagues showed that older adults in the Longitudinal Aging
Study Amsterdam who had serum 25(OH)D concentrations below
25 nmol/L were twice as likely to have sarcopenia (defined as loss of
grip strength or loss of appendicular skeletal muscle mass) over a
3-year follow-up period, when compared with participants who
had higher (>50 nmol/L) concentrations [73]. Furthermore, in
continued follow-up of this cohort, lower vitamin D status at
baseline was associated with a higher future risk of nursing home
admission [74]. Proximal weakness is a feature of clinical vitamin D
deficiency, with suggestion from biopsy studies that severe defi-
ciency preferentially affects type II muscle fibres [63]. Consistent
with this observation, a number of epidemiological studies have
shownworse lower extremity function, such as longer walk and sit-
to-stand times, among older adults who have low vitamin D statusPlease cite this article in press as: Robinson SM, et al., Does nutrition pla
Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.08.016[75,76]. However, in comparison with such evidence of functional
benefits of higher vitamin D status, the effects on muscle mass and
composition are less clear [77]. In younger adults, serum 25(OH)D
concentrations have been shown to be inversely related to
measured muscle fat infiltration, an effect that was independent of
differences in body mass index and activity levels [78]. Such
changes in muscle lipid content have important implications for
musculoskeletal function; for example, in the Health ABC study,
older adults with high mid-thigh intramuscular fat content (in top
quarter) had a 58% increased risk of hip fracture over a 7-year
follow up period, when compared with those in the lowest
quarter, and a higher incidence of mobility limitations [79].
Although attenuated, the difference in fracture risk remained after
adjustment for differences in muscle strength and physical per-
formance (SPPB) [80].
As low vitamin D status is common in many older populations
[81], much attention has been focused on the potential therapeutic
benefits of supplementation. A systematic review and meta-
analysis of trials of vitamin D supplementation to improve
strength and function of older adults was published in 2011; in 10 of
the 12 studies included in the systematic review that reported
baseline vitamin D status, participants' mean serum 25(OH)D
concentrations were in the deficiency range (<50 nmol/L) [82].
Supplementation with vitamin D was shown to have beneficial ef-
fects on muscle function, with evidence of reduced postural sway,
decreased time for the Timed Up and Go test, and gains in lower
extremity strength [82]. More recently, a larger meta-analysis of 29
vitamin D supplementation trials has confirmed a small but positive
effect on muscle strength [83]. However, benefits of supplementa-
tion may be confined to adults of lower vitamin D status. This was
described by Stockton and colleagues in a meta-analysis of 17 RCTs;
there was no significant effect of vitamin D supplementation on
muscle strength (grip or proximal lower limb) in adults with serum
25(OH)D concentrations >25 nmol/L, but using pooled data from
two studies of vitamin D deficient participants (25(OH)
D < 25 nmol/L), a large effect of supplementation on hip muscle
strength was observed [84]. Differences in strength in response to
supplementation, according to status at baseline, were also
observed in the largermeta-analysis [83], andmay explain negative
findings in some trials. For example, vitamin D supplementation
(800 IU/d) did not improve physical function in a recent study of
older Finnish women; but as fluid milk products are fortified in
Finland, status may have been too high to show benefits [85].
There have been a number of trials of vitamin D supplementa-
tion to prevent falls in older adults. Apart from potential effects of
vitamin D on muscle mass and strength, low status has also been
linked to orthostatic hypotension [86], commonly considered to be
a risk factor for falls [87]. To date, ten meta-analyses of fall pre-
vention trials have been published (Table 1).
With the exception of one meta-analysis, that did not show
benefits of supplementation [97], the remaining studies described ay a role in the prevention and management of sarcopenia?, Clinical
S.M. Robinson et al. / Clinical Nutrition xxx (2017) 1e126reduction in rates of falls that range from 12% to 37% following
vitamin D supplementation. However, an important addition to this
evidence has recently come from the Zurich Disability Prevention
Trial [98]. In this RCT, community-dwelling older men and women
with a prior fall were allocated to have monthly treatments with
24,000 IU of vitamin D3 (equivalent to 800 IU/day; reference
group), 60,000 IU, or 24,000 IU of vitamin D3 plus 300 mg of cal-
cifediol over one year. The majority of participants (58.0%) were
vitamin D deficient (<20 ng/mL) at baseline. Intention-to-treat
analyses showed that, while the higher dose and combined dose
groups were more likely to achieve 25-hydroxyvitamin D levels of
at least 30 ng/mL at 12 months (P ¼ 0.001), mean changes in
function (SPPB) did not differ among the treatment groups
(P ¼ 0.26). More than half the participants (60.5%) fell during the
12-month follow-up period; a higher incidence of falls was found in
the 60 000 IU group (67%; 95% CI, 54e78) and the 24 000 IU plus
calcifediol group (66%; 95% CI, 54e77%) group when compared
with the 24 000 IU reference group (48%; 95% CI, 36%e60%)
(P ¼ 0.048) [98]. Overall, fewest falls were observed among par-
ticipants with vitamin D status in the lower replete range of 25(OH)
D (21.3e30.3 ng/ml) with most falls observed in the range
44.7e98.9 ng/ml. This finding is consistent with an increased risk of
falls observed in another trial of vitamin D supplementation; older
community-dwelling women at risk of fracture, who received an
annual oral dose of 500,000 IU cholecalciferol, had 15% more falls
than other women [99]. It is possible that there is a therapeutic
range of vitamin D status required to prevent falls in older age.
In summary, there is significant evidence of potential benefits of
use of supplemental vitamin D to preserve muscle mass, strength
and physical function in older age and to prevent and treat sarco-
penia. Additionally, data from the PROVIDE Study suggest that
supplementation with vitamin D in combination with other nutri-
ents may be important; in this trial, provision of a supplement,
containing vitamin D, leucine-enrichedwhey protein and amixture
of micronutrients, over a 13-week period, resulted in greater gains
in appendicular muscle mass and improved chair rise time in sar-
copenic older adults, when comparedwith a control group given an
isocaloric supplement (without protein or micronutrients) [100].
However, further data from large clinical trials that test the benefits
of supplementary vitamin D, and establish therapeutic ranges, are
needed. An example is the ongoing DO-HEALTH study (http://do-
health.eu/wordpress/), conducted across seven European cities
(2  2  2 factorial design trial over a 3-year period: home exercise
program and/or vitamin D, and/or omega-3 fatty acids) that will
provide key information on the individual and combined effects of
these treatments on the risk of functional decline in older age.
3.3. Antioxidant nutrients
Markers of oxidative damage have been shown to predict im-
pairments in physical function in older adults [101]. Damage to
biomolecules such as DNA, lipid and proteins may occur when
reactive oxygen species (ROS) are present in cells in excess. The
actions of ROS are normally counterbalanced by antioxidant
defence mechanisms that include the enzymes superoxide dis-
mutase and glutathione peroxidase, as well as exogenous antioxi-
dants derived from the diet, such as selenium, carotenoids,
tocopherols, flavonoids and other plant polyphenols [101]. As an
accumulation of ROS may lead to oxidative damage, with the po-
tential to contribute to losses of muscle mass and strength in older
age [102], there is interest in the role of dietary antioxidants and
their effects on age-related losses in muscle mass and function.
A number of observational studies have shown positive associ-
ations between higher antioxidant status and measures of physical
function [21], and more recently, low selenium status has beenPlease cite this article in press as: Robinson SM, et al., Does nutrition pla
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tantly, associations with antioxidant nutrients have been found
both in cross-sectional analyses [104] and in longitudinal studies
[105]. Poorer status is predictive of decline in function, and the
observed effect sizes are large. For example, among older men and
women in the InCHIANTI study, higher plasma carotenoid con-
centrations were associated with a lower risk of developing a se-
vere walking disability over a follow-up period of 6 years; after
taking account of confounders that included level of physical ac-
tivity and other morbidity, the odds ratio was 0.44 (95% CI
0.27e0.74) [105]. Inverse associations have also been described for
vitamin E and selenium status in relation to risk of impaired
physical function [21]. However, in general, trials of antioxidant
supplementation to prevent disease have not had the effects pre-
dicted from epidemiological studies [106,107]; to date, there is little
trial evidence in relation to muscle outcomes, and none to deter-
mine the effects of antioxidant supplementation in sarcopenic in-
dividuals. The benefits of antioxidant supplementation to prevent
or treat sarcopenia are therefore uncertain [108].
Additionally, as ROS have both physiological and pathological
roles, interventions based on simple suppression of their activities
may be unlikely to improve age-related declines in muscle mass
and function [109]. Important evidence, consistent with the pro-
posed lack of benefit of antioxidant supplements, has come from a
recent trial that investigated the effects of vitamin C (500 mg/day)
and E (117.5 mg/day) supplementation on muscle mass and
strength in a group of older (60e81 years) menwho participated in
a 12-week period of strength training [110]. DXA-assessed body
composition at follow-up revealed a smaller increase in total lean
mass in the supplemented group (1.4% (95% CI 0, 5.4) vs 3.9% (3.0,
5.2)), and lower gains in muscle thickness (rectus femoris). The
authors' conclusion, that high-dose vitamin C and E supplemen-
tation blunted some of the muscular adaptations to strength
training in older men [110], raises significant concerns about the
use of antioxidant supplements to prevent age-related losses of
muscle mass and strength, particularly in relation to strength
training. But further evidence is needed.
3.4. Long-chain polyunsaturated fatty acids
Low-grade systemic inflammation, involving increases in the
production of inflammatory factors, such as C-reactive protein
(CRP), tumour necrosis factor-a (TNF-a) and interleukin 6 (IL-6),
and recognised to have an important role in numerous chronic
conditions [111], has also been implicated in age-related disease
[112,113]. For example, inflammation has been shown to predict
incident mobility limitation [114], and, in a 10-year follow-up of the
older participants in the Hertfordshire Ageing Study, ‘inflammag-
ing’ burden (defined by blood concentration of inflammatory bio-
markers) at baseline was associated with lower grip strength at
follow-up [115]. Since eicosanoids derived from 20-carbon poly-
unsaturated fatty acids are among the mediators and regulators of
inflammation [116], this raises the possibility that variations in
dietary intakes of n-3 and n-6 long chain polyunsaturated fatty
acids (LCPUFAs), and their balance in the diet, could be of impor-
tance [117]; in particular, n-3 LCPUFAs have the potential to be
potent anti-inflammatory agents [118]. In a recent meta-analysis
that included 68 trials, supplementation with marine-derived n-3
LCPUFAs was shown to have a significant lowering effect on CRP,
IL-6 and TNF-a levels, with longer duration of supplementation
associated with greater change [111].
However, apart from effects on the inflammatory response,
there is now also increasing evidence of direct effects of omega-3
fatty acids on muscle protein synthesis; acting via effects on
mTOR signalling; with the suggestion that n-3 fatty acidy a role in the prevention and management of sarcopenia?, Clinical
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adults by over-coming age-related effects on anabolic resistance
[119]. In a randomised controlled trial, supplementation of older
adults with n-3 LCPUFA (eicosapentaenoic and docosahexaenoic
acids) had no effect on the basal rates of muscle protein synthesis,
when compared with adults given corn oil, but the increase in the
rate of muscle protein synthesis during a hyperaminoacidemic-
hyperinsulinemic clamp was ~3-fold greater. This effect appeared
to be at least partially mediated via changes in the muscle mTOR
signalling pathway (Fig. 5) [120].
These novel data, showing augmentation of the anabolic
response, are consistent both with evidence from animal and
in vitro models that support a stimulatory effect of omega-3 fatty
acids on muscle protein synthesis after feeding [119], and with
findings from younger adults [120].
There is some observational evidence that supports the positive
benefits of diets higher in n-3 LPUFAs for muscle strength and
measured physical function [121,122], and in a large study of
women aged 18e79 years, a higher dietary polyunsaturated:
saturated fatty acid ratio was associated with a greater fat-free
mass, which may be suggestive of muscle conservation [123].
Supplementation studies of older women to increase intakes of n-3
LCPUFAs have achieved improvement in walking speed [124], and
in a strength-training trial, the use of fish oil supplements (2 g/day)
resulted in greater improvements in muscle strength and func-
tional capacity when compared with women who participated in
strength training alone [125]. In a trial of n-3 LCPUFA supplemen-
tation (1.86 g eicosapentaenoic acid (EPA), 1.50 g docosahexaenoic
acid (DHA)) of older adults aged 60e85 years, thigh muscle volume
increased over a 6-month follow-up period in supplemented group,
whereas there was no change in the control group who were given
corn oil. Muscle strength at follow-up was also greater in the
supplemented group [126]. Importantly, the treatment effects (in-
creases in muscle volume: 3.6% (95% CI 0.2, 7.0%; handgrip
strength: 2.3 kg; 95% CI: 0.8, 3.7 kg)) are clinically relevant,
approximating expected losses over a 2e3-year period [119].
These new data offer promise of a simple low-cost approach for
the prevention and treatment of age-related losses of muscle mass
and function in older age. However, considerable gaps in our
knowledge remain [119]. One challenge is that not all supplemen-
tation trials are effective. For example, in a recent trial of n-3
LCPUFA supplementation of 53 older women with low muscle
mass, there were no differences in muscle mass, hand grip or TUG
in any group over a 12-week follow-up when comparing the sup-
plemented and placebo groups [127]. Some of the inconsistency inFig. 5. Mean (±SEM) mixed skeletal muscle protein fractional synthesis rate (FSR) dur
before and after 8 weeks of supplementation with corn oil or n-3 fatty acids (a :signifi
different from the corresponding value before omega-3 fatty acid supplementation, P < 0.0
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Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.08.016findings across studies may be due to methodological differences,
particularly in dose and duration of studies, status of participants
studied and methods of assessment of outcome e and further trial
data are needed. Particular questions relate to the dose-dependent
nature of effects, the latency and duration of the beneficial re-
sponses, and the individual roles of EPA and DHA in the regulation
of muscle function [119].
3.5. Foods and dietary patterns
A limitation of the observational evidence that links individual
nutrients to differences in muscle mass and function in older age is
that many dietary components are highly correlated with each
other. Whilst this challenges any causal inferences that can be
drawn, it also means that intakes of individual nutrients may act as
markers for other components, including a range of bioactive
compounds, such as plant phytochemicals. There is less evidence
on the effects of whole foods, or that use whole-diet approaches to
understand the role of diet in the aetiology of age-related losses of
musclemass and function, although this is a rapidly growing area of
interest.
3.5.1. Dairy foods
One of the types of foods most studied in relation to muscle
mass and function is dairy products. They may be important due to
their whey protein content, which is relatively high in branched-
chain amino acids [128] and that also has antioxidant properties
[129]. In a cross-sectional study of a large Australian population of
older women, high dairy consumption (milk, yogurt, and cheese)
was associated with greater lean mass and appendicular skeletal
muscle mass, and with greater grip strength and lower odds for a
poor Timed-Up-and-Go test [130]. There is some experimental
evidence to support these observational data; for example the
addition of ricotta cheese (210 g/day) to the diets of older men and
women over a 12-week period improved appendicular skeletal
muscle mass and balance, when compared with a control group
who were following habitual diets [131]. Amino acid balance
studies suggest that ingestion of milk following resistance exercise
increases amino acid uptake, indicative of net muscle protein
synthesis [132], and a number of studies have investigated the
combined effects of dairy protein supplements with exercise
training. Among younger adults undergoing 12 weeks of resistance
training, those given a milk drink after exercise achieved greater
gains in lean mass and greater losses in fat mass when compared
with participants given an isocaloric carbohydrate drink [133]; theing postabsorptive conditions and hyperaminoacidemic-hyperinsulinemic clamp,
cant effect of clamp, P < 0.01; b: significant effect of clamp P < 0.01; c: significantly
1) [120].
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exercises. In a separate study of overweight and obese women,
Josse and colleagues have also shown more favourable body
composition changes (greater total and visceral fat loss, lean mass
gain) in response to a diet and exercise regime among women
randomized to a high-protein, high-dairy group, when compared
with other women with adequate protein but medium/low dairy
foods [134].
However, other studies have not found effects of combining
exercise trainingwith dairy food supplements. In an 18-month trial,
designed to assess the use of fortified milk to enhance the effects of
resistance training in men aged 50e79 years, there were no effects
on skeletal muscle size, strength or function [135]. A possible
explanation of these disparate findings is that the timing of milk
consumption after exercise is key to its benefits, which was not
closely controlled in this study; although a recent meta-analysis
suggests that timing of protein intake may not be critical to
muscular adaptations to exercise training [136]. Whilst one chal-
lenge in collating data across studies is the difference in the status
and age of participants, another is the compositional differences
across apparently similar dairy foods. The most notable difference
may be the fortification of milk with vitamin D in some countries
(eg US) but not others (eg UK). Benefits of soya milk consumption
after exercise have not been shown [137]. Furthermore, in a recent
study of older adults, those with increased soy protein intake had
lower gains in muscle strength during resistance training when
compared to participants with increased dairy protein intakes or
usual intakes; there were no differences between the dairy protein
and usual protein groups [138].
3.5.2. Nitrate-rich foods
Some anti-oxidant rich foods are also rich in inorganic nitrates,
for example green leafy vegetables like lettuce, spinach and celery,
and beetroot. Dietary nitrate ingestion appears to enhance exercise
capacity and performance in young individuals [139], and beetroot
juice has become popular among some endurance athletes. In the
body nitrate is converted to nitrite and to nitric oxide that is
pleiotropic and has effects on various muscle performance-related
functions that are related to muscle contraction efficiency. How-
ever, no long-lasting effects on for example protein synthesis have
been reported [140], and in a recent trial of consumption of beet-
root juice by older participants (60e75 years), short-term supple-
mentation did not modify measures of physical capability (walking
speed, time-up-and-go, repeated chair rising test, hand-grip
strength) [139]. Dietary nitrates have been discussed as a sup-
portive remedy in congestive heart failure [141], but there are no
studies in frail or sarcopenic older adults.
3.5.3. Dietary patterns
Since diets are patterned, and foods as well as nutrients are
collinear, isolating effects of individual dietary components is not
possible using observational data. It is therefore of value to consider
effects of whole diets, commonly using a dietary patterns approach.
An additional advantage of this approach is that it can also take
account of complex interactions between food constituents,
including potential synergistic or antagonistic effects on health
outcomes [142]. In general, ‘healthier’ diets that are characterised
by greater fruit and vegetable consumption indicate higher intakes
of a range of nutrients that could be important for muscle function,
such as greater consumption of oily fish and higher intakes of
vitamin D and n-3 LCPUFAs, and higher antioxidant and protein
intakes [121]. They are also higher in a range of plant phytochem-
icals, such as polyphenols, that may have important antioxidant
and anti-inflammatory effects on muscle mass and function [143].
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catabolism of the sulphur-containing amino acids and phytates,
and provide protection from known catabolic effects of acidosis on
muscle tissue [144]. Although the role of the dietary acid-base load
has not been extensively studied [145], there is evidence that links
more alkaline diets, rich in fruit and vegetables, to greater lean
tissue mass in middle-aged [145] and older adults [146], suggesting
they may have protective effects.
Compared with the evidence that links variations in nutrient
intake and status to physical function, less is known about the in-
fluence of dietary patterns and dietary quality in older age.
‘Healthier’ diets, characterised by greater fruit and vegetable con-
sumption, wholemeal cereals and oily fish have been shown to be
associated with greater muscle strength and with better measures
of physical function in older adults [121,147e149] and lower risk of
frailty [150]. However, the most significant body of evidence, based
on longitudinal studies of older adults, considers compliancewith a
Mediterranean dietary pattern; high pattern scores at baseline are
related to better self-reported physical function [151], lower risk of
incident disability [152], lower decline in measured physical func-
tion and lower risk of developing mobility disability [153,154], and
better walking performance [155] The consistency in this obser-
vational evidence suggests that intervention studies that take a
food-based or ‘whole diet’ approach, resulting in changes in intakes
of a range of nutrients and other food constituents, have potential
to be very effective strategies for the prevention and/or treatment
of age-related losses in muscle mass and strength.
4. Conclusions
The considerable evidence that links nutrition to muscle mass,
strength and function of older adults, suggests that nutrition has an
important role to play in both the prevention and management of
sarcopenia. It points to the importance of dietary patterns that are
adequate in quality for older adults, to ensure sufficient intakes of
protein, vitamin D, antioxidant nutrients and long-chain poly-
unsaturated fatty acids. Since much of the evidence is observational
and from high-income countries, further high quality trials,
particularly from more diverse populations, are needed to enable
an understanding of dose and duration effects of individual nutri-
ents on function, to elucidate mechanistic links, and to define
optimal profiles and patterns of nutrient intake for older adults.
Future work should also consider the role of targeted interventions
to reach more vulnerable sub-groups of the population who have
specific phenotypic characteristics, or who differ according to stage
of sarcopenia, or in their habitual diets and nutrient status [156].
This will contribute to evidence of the functional effects of varia-
tions in nutrient intake needed to inform dietary recommendations
and to allow scale-up to population level. However, the high
prevalence of poor nutrition currently observed among older
populations, including in high-income countries, highlights the
immediate need to ensure all older adults are supported effectively
to have sufficient dietary intakes and adequate nutritional status.
Whilst routine screening and early diagnosis of malnutrition are
key components of such strategies, wider efforts to promote diet
quality alongside a physically active lifestyle are also essential; they
have significant potential to slow losses of muscle mass and
strength and protect physical function, central to enabling mobility
and independence in older age.
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